You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pan-RAF

Showing 1 - 25 of 408
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Low-grade Glioma Trial (Tovorafenib)

Available
  • Low-grade Glioma
  • (no location specified)
Feb 23, 2023

Advanced Solid Tumors Harboring MAPK Pathway Alterations Trial in Shandong (QLH11906)

Recruiting
  • Advanced Solid Tumors Harboring MAPK Pathway Alterations
  • Shandong, China
    Shandong Cancer Hospital
Aug 3, 2022

Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial (Biopsy, Biospecimen Collection,

Not yet recruiting
  • Recurrent Langerhans Cell Histiocytosis
  • Refractory Langerhans Cell Histiocytosis
  • Biopsy
  • +3 more
  • (no location specified)
Dec 22, 2022

Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial in United States (Biospecimen

Recruiting
  • Recurrent Langerhans Cell Histiocytosis
  • Refractory Langerhans Cell Histiocytosis
  • Biospecimen Collection
  • +8 more
  • Wilmington, Delaware
  • +3 more
Apr 28, 2023

Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)

Recruiting
  • Low-grade Glioma
  • Advanced Solid Tumor
  • San Francisco, California
  • +35 more
May 25, 2022

Pediatric Cancer, CNS Tumor, Childhood, Skin Inflammation Trial in Boston (other, drug, behavioral)

Recruiting
  • Pediatric Cancer
  • +2 more
  • Warm Baths or Showers
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jan 31, 2022

Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

Not yet recruiting
  • Low-grade Glioma
  • (no location specified)
Oct 3, 2022

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Craniopharyngioma, Child, Craniopharyngioma, Recurrent Craniopharyngioma Trial in San Francisco (Nivolumab, DAY101)

Not yet recruiting
  • Craniopharyngioma, Child
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jul 15, 2022

NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

Terminated
  • NSCLC
  • +3 more
  • Boston, Massachusetts
  • +17 more
Dec 20, 2022

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Recruiting
  • Unknown Primary Tumors
  • DNA Methylation
    • Guangzhou, Guangdong, China
      Sun Yat-sen university cancer center
    Nov 20, 2023

    Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial

    Not yet recruiting
    • Malignant Female Reproductive System Neoplasm
    • +3 more
    • Biopsy
    • +7 more
    • (no location specified)
    Nov 9, 2023

    Pan Immune Inflammatory Index and Endometriosis

    Active, not recruiting
    • Relationship Between Pan Immune Inflammatory Index and Endometriosis and Endometriosis Stages
      • Ankara, Yenimahalle, Turkey
        Ankara Etlik City Hospital
      Nov 16, 2023

      Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)

      Recruiting
      • Solid Tumor
      • EGFR Amplification
      • Tianjin, Tianjin, China
        Tianjin Medical University Second Hospital
      Aug 28, 2023

      Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

      Recruiting
      • Solid Tumor
      • +4 more
      • Tianjin, Tianjin, China
        Tianjin Medical University Second Hospital
      Aug 28, 2023

      Tumor, Solid Trial in Caen, Lille (RCMI in painting dose on histoscannographic mapping, Standard pan-sinusal IMRT)

      Not yet recruiting
      • Tumor, Solid
      • RCMI in painting dose on histoscannographic mapping
      • Standard pan-sinusal IMRT
      • Caen, France
      • +2 more
      Jul 5, 2023

      Cancer, Cancer Gene Mutation, PAN Gene Mutation Trial in Scottsdale, Jacksonville, Rochester (Pan-genomic Testing)

      Not yet recruiting
      • Cancer
      • +2 more
      • Pan-genomic Testing
      • Scottsdale, Arizona
      • +2 more
      Aug 18, 2023

      Thyroid Cancer Trial in United States (Avutometinib, Defactinib)

      Recruiting
      • Thyroid Cancer
      • Basking Ridge, New Jersey
      • +6 more
      Aug 17, 2023

      Diabetes, Type 2 Trial (Methodological intervention, Toujeo)

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • Methodological intervention
      • Toujeo
      • (no location specified)
      Mar 21, 2023

      BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

      Recruiting
      • BRAF V600E
      • Metastatic Colorectal Cancer
      • Beijing, Beijing, China
      • +33 more
      Dec 20, 2022

      Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

      Recruiting
      • Cancer
      • +2 more
      • Cellworks Report
      • Sioux Falls, South Dakota
        Avera Cancer Institute
      Jan 20, 2023

      Advanced Solid Tumor, RAS Mutation, RAF Mutation Trial in Houston, Irving (ABM-168)

      Recruiting
      • Advanced Solid Tumor
      • +3 more
      • Houston, Texas
      • +1 more
      Apr 14, 2023

      Malaria Trial in Lambaréné (Vaccine AnAPN1)

      Not yet recruiting
      • Malaria
      • Vaccine AnAPN1
      • Lambaréné, Moyen- Ogooué, Gabon
        Centre de Recherches Médicales de Lammbaréné
      Jun 21, 2023

      PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only

      Not yet recruiting
      • PARP Inhibitor for Esophageal Squamous Cell Carcinoma
      • Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
      • (no location specified)
      Sep 24, 2023

      Atrial Fibrillation Trial in Tanta (Measuring Serum bio-markers)

      Completed
      • Atrial Fibrillation
      • Measuring Serum bio-markers
      • Tanta, Egypt
        Tanta university
      Nov 5, 2021